Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
AIMS: In this study, we sought to determine the role of ecto-nucleotidases and adenosine receptors in calcific aortic valve disease (CAVD). The expression of ecto-nucleotidases, which modify the levels of extracellular nucleotides/nucleosides, may control the mineralization of valve interstitial cells (VICs). We hypothesized that expression of ectonucleotide pyrophosphatase/phosphodiesterase 1 (NPP1), which generates AMP, and 5'-nucleotidase (CD73), an enzyme using AMP as a substrate to produce adenosine, may co-regulate the mineralization of the aortic valve. METHODS AND RESULTS: We have investigated the expression of NPP1 and 5'-nucleotidase in CAVD tissues and determined the role of these ecto-nucleotidases on the mineralization of isolated VICs. In CAVD tissues (stenotic and sclerotic), we documented that NPP1 and 5'-nucleotidase were overexpressed by VICs. In isolated VICs, we found that mineralization induced by adenosine triphosphate was decreased by silencing NPP1 and 5'-nucleotidase, suggesting a role for adenosine. Adenosine and specific A2a adenosine receptor (A2aR) agonist increased the mineralization of VICs. Silencing of A2aR in human VICs and the use of A2aR(-/-) mouse VICs confirmed that A2aR promotes the mineralization of cells. Also, A2aR-mediated mineralization was negated by the transfection of a mutant dominant-negative Gαs vector. Through several lines of evidence, we next documented that adenosine stimulated the mineralization of VICs through a cAMP/protein kinase A (PKA)/cAMP response element-binding protein (CREB) pathway, and found that CREB positively regulated the expression of NPP1 in a positive feedback loop by physically interacting with the promoter. CONCLUSION: Expression of NPP1 and 5'-nucleotidase by VICs promotes the mineralization of the aortic valve through A2aR and a cAMP/PKA/CREB pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several ectonucleotidases such as ALP, ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) and 5′-nucleotidase (5′-NT, also called CD73) are overexpressed in human stenotic aortic valves”
From Calcific aortic stenosis (2016) · cites this paper as [111]
In the citing paper
“the over activity of E-NPP 1 and 5′-NT in human stenotic aortic valves depletes extracellular ATP and produces adenosine111.”
From Calcific aortic stenosis (2016) · cites this paper as [111]
Citations
Cites
Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL
Heinemeyer, T. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.362 · Cited by 1,451
Yegutkin, G. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.024 · Cited by 1,154 · cited 1×
“Also, it is possible that, by producing AMP, NPP1 modulates the signalling through adenosine receptors.(10) To this effect, 5′-nucleotidase (CD73) is using AMP as a substrate to produce adenosine, which could exert a control over the mineralization of the aortic valve.”
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030 · cited 2×
“Therefore, in conditions where NPP1 and 5′-nucleotidase are co-expressed and up-regulated, it is likely that adenosine will be produced and therefore will modulate the function of adenosine receptors.(22) We found that HVICs expressed a high level of NPP1 and 5′-nucleotidase.”
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842
Self-citationThe Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology
Liu, A. C., Joag, V. R., & Gotlieb, A. I. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070251 · Cited by 632
NT5E Mutations and Arterial Calcifications
St. Hilaire, C., Ziegler, S. G., Markello, T. C., Brusco, A., Groden, C., Gill, F., Carlson-Donohoe, H., Lederman, R. J., Chen, M. Y., Yang, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0912923 · Cited by 455
Okawa, A., Nakamura, I., Goto, S., Moriya, H., Nakamura, Y., & Ikegawa, S. (1998) · Nature Genetics · doi:10.1038/956 · Cited by 422 · cited 1×
“PPi is a strong inhibitor of mineralization and NPP1 knockout mice develop ectopic mineralization of tendons.(5) On the other hand, overexpression of NPP1 in VICs and chrondrocytes”
Messika-Zeitoun, D., Aubry, M.-C., Detaint, D., Bielak, L. F., Peyser, P. A., Sheedy, P. F., Turner, S. T., Breen, J. F., Scott, C., Tajik, A. J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000135469.82545.d0 · Cited by 386
Caira, F. C., Stock, S. R., Gleason, T. G., McGee, E. C., Huang, J., Bonow, R. O., Spelsberg, T. C., McCarthy, P. M., Rahimtoola, S. H., & Rajamannan, N. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.040 · Cited by 371
Goding, J. W., Grobben, B., & Slegers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00058-9 · Cited by 364 · cited 6×
“Accordingly, a recent report has also documented that porcine VICs express 5′-nucleotidase.23 Transforming growth factor-b1, a growth factor suspected to play a role in CAVD, is also a positive regulator of NPP1.”
Influential
Cited by
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Self-citationCalcific aortic valve disease: mechanisms, prevention and treatment
Moncla, L.-H. M., Briend, M., Bossé, Y., & Mathieu, P. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00845-7 · Cited by 306
Self-citationHadji, F., Boulanger, M.-C., Guay, S.-P., Gaudreault, N., Amellah, S., Mkannez, G., Bouchareb, R., Marchand, J. T., Nsaibia, M. J., Guauque-Olarte, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.023116 · Cited by 223
Self-citationMedical Treatment of Aortic Stenosis
Marquis-Gravel, G., Redfors, B., Leon, M. B., & Généreux, P. (2016) · Circulation · doi:10.1161/circulationaha.116.023997 · Cited by 162
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications
Greenberg, H. Z. E., Zhao, G., Shah, A. M., & Zhang, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab142 · Cited by 123
Nsaibia, M. J., Boulanger, M.-C., Bouchareb, R., Mkannez, G., Le Quang, K., Hadji, F., Argaud, D., Dahou, A., Bossé, Y., Koschinsky, M. L., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx089 · Cited by 95
“Human VICs were obtained from non-mineralized aortic valves (heart transplantation; see Supplementary material online, Table S1) and treated with a mineralizing medium for 7 days.(18) VIC cultures treated with OxLDL (100 ng/mL) (copper-treated LDL isolated from healthy donors; see Supplementary material online, Table…”
MethodSelf-citationExtracellular Matrix in Calcific Aortic Valve Disease: Architecture, Dynamic and Perspectives
Vito, A. D., Donato, A., Presta, I., Mancuso, T., Brunetti, F. S., Mastroroberto, P., Amorosi, A., Malara, N., & Donato, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020913 · Cited by 94
“It is remarkable the fact that several ectonucleotidases involved in nucleation of calcium and phosphate, such as alkaline phosphatase (ALP), ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) and 5′-nucleotidase (5′-NT, also called CD73), are overexpressed in extracellular vesicles [45,61].”
BackgroundDecano, J. L., Iwamoto, Y., Goto, S., Lee, J. Y., Matamalas, J. T., Halu, A., Blaser, M., Lee, L. H., Pieper, B., Chelvanambi, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110685 · Cited by 46
Boaru, D. L., León-Oliva, D. D., Castro-Martinez, P. D., Montero, C. G., Fraile‐Μartinez, O., García-González, B., Pérez-González, I., Alhaddadin, M. N. M., Barrena-Blázquez, S., López-González, L., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.119301 · Cited by 46
Dias, L., Lopes, C. R., Gonçalves, F. Q., Nunes, A. F., Pochmann, D., Machado, N. J., Tomé, Â. R., Agostinho, P. M., & Cunha, R. A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.639322 · Cited by 44
The role of ecto-5′-nucleotidase in endothelial dysfunction and vascular pathologies
Żukowska, P., Kutryb-Zając, B. A., Tomczyk, M., Smolenski, R. T., & Slominska, E. M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.05.002 · Cited by 44
Oury, C., Servais, L., Bouznad, N., Hego, A., Nchimi, A., & Lancellotti, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071120 · Cited by 43
“Expression of NPP1 and 5’-nucleotidase by VICs could mediate mineralization of the aortic valve through the adenosine A2 receptor [5].”
Atherosclerosis Calcification: Focus on Lipoproteins
Neels, J. G., Lefthériotis, G., & Chinetti, G. (2023) · Metabolites · doi:10.3390/metabo13030457 · Cited by 47
Wang, C., Zhang, Y., Methawasin, M., Braz, C. U., Gao-Hu, J., Yang, B., Strom, J. G., Gohlke, J., Hacker, T. A., Khatib, H., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.01.004 · Cited by 29
Ullah, S., El-Gamal, M. I., El‐Gamal, R., Pelletier, J., Sévigny, J., Shehata, M. K., Anbar, H. S., & Iqbal, J. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113339 · Cited by 29
Deletion of CD73 in mice leads to aortic valve dysfunction
Żukowska, P., Kutryb-Zając, B. A., Jasztal, A., Tomczyk, M., Zabielska-Kaczorowska, M. A., Borkowski, T., Khalpey, Z. I., Smolenski, R. T., & Slominska, E. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.02.008 · Cited by 25
Kutryb-Zając, B. A., Jabłońska, P., Serocki, M., Braczko, A., Mierzejewska, P., Friebe, D., Alter, C., Jasztal, A., Lango, R., Rogowski, J. A., et al. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01495-x · Cited by 24
Yang, Y., Li, X., Xiao, S., Qin, W. D., Ren, L., Yao, Y., & Liu, N. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321682 · Cited by 22
Zhang, M., Dai, X., Xiang, Y., Xie, L., Sun, M., & Shi, J. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115546 · Cited by 21
Opdebeeck, B., Orriss, I. R., Neven, E., D’Haese, P. C., & Verhulst, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207636 · Cited by 16
“In line with these results, activation of the A2A receptor promoted the mineralization process in VIC cultures by favoring the cAMP/protein kinase A pathway, while activation of the A1 receptor resulting in decreased cAMP levels, inhibited VIC mineralization [31].”
BackgroundResultSimões, A. P., Gonçalves, F. Q., Rial, D., Ferreira, S. G., Lopes, J. P., Canas, P. M., & Cunha, R. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112826 · Cited by 15
“A similar association of CD73 and A2AR was concluded in other cells or tissues such as neuromuscular junction [52], astrocytes [53], “activated” microglia [54,55], neutrophils [56], B cell lymphocytes [57], T cell lymphocytes [58], fibroblasts [59], cardiac valve interstitial cells [60] or mesenchymal stem cells [61].”
BackgroundWeber, A., Barth, M., Selig, J. I., Raschke, S., Dakaras, K., Hof, A., Hesse, J., Schrader, J., Lichtenberg, A., & Akhyari, P. (2018) · The FASEB Journal · doi:10.1096/fj.201701326r · Cited by 14
“scribed impact of A2A receptor activation, our study revealed that activation of A2B can potentially promote degeneration processes of VICs (19).”
BackgroundInfluentialKudryavtsev, I. V., Серебрякова, М. К., Zhiduleva, E. V., Murtazalieva, P., Titov, V., Malashicheva, A., Shishkova, А. А., Semenova, D., Irtyuga, O. B., Isakov, D., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00604 · Cited by 12
Jabłońska, P., Kutryb-Zając, B. A., Mierzejewska, P., Jasztal, A., Bocian, B., Lango, R., Rogowski, J. A., Chłopicki, S., Smolenski, R. T., & Slominska, E. M. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15912 · Cited by 11
Olkowicz, M., Jabłońska, P., Rogowski, J. A., & Smolenski, R. T. (2018) · Talanta · doi:10.1016/j.talanta.2018.01.044 · Cited by 11
Yang, L., Yang, Y., Liu, X., Chen, Y. Q., Chen, Y., Lin, Y., Sun, Y., & Shen, B. (2020) · Database · doi:10.1093/database/baaa048 · Cited by 10
“The phenotypes of non-isolated CHD are more complex than those of isolated CHD in terms of nucleotide binding and interaction (44).”
BackgroundNassir, M., Arad, U., Lee, S.-Y., Journo, S., Mirza, S., Renn, C., Zimmermann, H., Pelletier, J., Sévigny, J., Müller, C. E., et al. (2019) · Purinergic Signalling · doi:10.1007/s11302-019-09649-2 · Cited by 10
Polymorphism in exon 6 of the human NT5E gene is associated with aortic valve calcification
Kochan, Z., Karbowska, J., Gogga, P., Kutryb-Zając, B. A., Slominska, E. M., & Smolenski, R. T. (2016) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2016.1180393 · Cited by 10
Regulation of CD73 in the development of lower limb atherosclerosis
Jalkanen, J. M., Hollmén, M., Jalkanen, S., & Hakovirta, H. H. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9545-0 · Cited by 10
“However, opposite to our findings, mature sclerotic valves obtained during valve replacement surgery still had a higher expression of CD73 when compared to completely healthy valves [19].”
BackgroundResultNassir, M., Pelletier, J., Arad, U., Arguin, G., Khazanov, N., Gendron, F., Sévigny, J., Senderowitz, H., & Fischer, B. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111754 · Cited by 10
Insights into preclinical models of calcific aortic valve disease and their translational potential
Lafosse, I., Mentaverri, R., Avondo, C., Bennis, Y., Tribouilloy, C. M., & Hénaut, L. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1621990 · Cited by 8
Kaniewska, E., Kutryb-Zając, B. A., Sarathchandra, P., Pelikant‐Małecka, I., Sielicka, A., Piotrowska, I., Slominska, E. M., Chester, A. H., Yacoub, M. H., & Smolenski, R. T. (2018) · Cardiovascular Pathology · doi:10.1016/j.carpath.2018.05.008 · Cited by 8
Macrophages as key modulators of calcific aortic valve disease
Issa, N., Blot, G., Candellier, A., Boudot, C., Louvet, L., Kamel, S., Bennis, Y., & Hénaut, L. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1664067 · Cited by 7
Kaniewska, E., Mielcarek, M., Chester, A. H., Slominska, E. M., Yacoub, M. H., & Smolenski, R. T. (2016) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2016.1163377 · Cited by 6
“observed that CD73/NT5E is overexpressed in human explanted calcified aortic valves and promotes an osteogenic activity in valve interstitial cells (11).”
BackgroundWeiß, L., Turner, M. E., Qin, Z., Bäck, M., & Aïkawa, E. (2026) · European Heart Journal - Valvular and Structural Heart Disease · doi:10.1093/ehjvshd/xwag018 · Cited by 5
Opdebeeck, B., den Branden, A. V., Adriaensen, S., Orriss, I. R., Patel, J. J., Geryl, H., Zwijsen, K., D’Haese, P. C., & Verhulst, A. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziae057 · Cited by 4
“30,31 More-over, silencing Enpp1 expression or using an NPP1 inhibitor, quinazoline-4-piperidine sulfamide, prevented the mineralization and the expression of osteo-/chondrogenic marker genes in aortic valve interstitial cells.”
BackgroundKutryb-Zając, B. A., Yuen, A. H. Y., Khalpey, Z. I., Żukowska, P., Slominska, E. M., Taylor, P. M., Goldstein, S., Heacox, A. E., Lavitrano, M., Chester, A. H., et al. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9672-6 · Cited by 4
“However, the role of adenosine and enzymes responsible for its metabolism in CAVD still raises controversy [26].”
BackgroundNassir, M., Arad, U., Lee, S.-Y., Journo, S., Mirza, S., Zimmermann, H., Pelletier, J., Sévigny, J., Müller, C. E., & Fischer, B. (2019) · Purinergic Signalling · doi:10.1007/s11302-019-09671-4 · Cited by 3
Zhou, Y., Zhao, D., Ma, Q., Lee, S., Roh, K., Cai, Y., Xu, J., Yang, Q., Da, Q., Liu, Z., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108012 · Cited by 2
“In addition, ADORA2A coupled with G α s promotes adenosine-induced mineralization of valve interstitial cells (VICs) [38].”
Editorial highlights from Cardiovascular Research
Gal, D., Sipido, K. R., & Vandevelde, W. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx210 · Cited by 2
Chen, Y.-X., Zhang, X., Cooper, D. N., Wu, D., & Bao, W.-D. (2025) · BMC Biology · doi:10.1186/s12915-025-02192-0 · Cited by 1
“…reports that mesodermal inhibition of the cAMP responsive element-binding proteins (CREBs), a TF family acting downstream of the cAMP pathway [63, 64] as their names describe, caused defective segmentation and somite polarity [65, 66], this signaling pathway could be a potentially important…”
Kutryb-Zając, B. A., Kawecka, A., Harasim, G., Bieńkowski, M., Stawarska, K., Urbanowicz, K., Smolenski, R. T., Kowalik, M. M., Kołaczkowska, M., & Siondalski, P. (2025) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2025.2502033 · Cited by 1
“…been demonstrated that extracellular nucleotide metabolism pathways contribute significantly to chronic inflammation, cell differentiation and tissue mineralization by controlling P1 and P2 purinergic receptor effects via modulation of extracellular nucleotide and adenosine concentrations [19,20].”
Monocytes at the crossroads of aortic stenosis and myocardial damage
Issa, N., Candellier, A., Boudot, C., Capoulade, R., Ghamlouch, H., Bäck, M., Fraineau, S., Bennis, Y., Eltchaninoff, H., Kamel, S., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf186 · Cited by 1
Garza, M. T. G. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.76869 · Cited by 1
“CD73 has been related with cardiopathies as ADO produced by the 5′-nucleotidase activity of CD73 could exert control over the mineralization of the aortic valve [24].”
BackgroundMolecular Mechanisms of Aortic Valve Pathology
Mkannez, G., Argaud, D., Boulanger, M., & Mathieu, P. (2019) · Springer eBooks · doi:10.1007/978-3-7091-4874-7_5
Self-citationCommentary: Molecular pathogenesis of aortic stenosis: Will the puzzle pieces ever fit together?
Shih, E., Squiers, J. J., Baxter, R. D., & DiMaio, J. M. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.10.010
“The biological process underlying the development of AS remains an area of intensive investigation—a cursory search of the literature revealed more than 20 papers examining potential genetic pathways impacting AS published within the last 5 years alone (Table 1).(5-25) Nevertheless, there are currently no available pr…”
BackgroundAdenosine Receptor Agonists And CD73 Effects On Avm Cell Calcification Markers
Koliopoulos, T. (2019) · UA Campus Repository (The University of Arizona) · Cited by 1
Forkhead Box Protein O1 (FoxO1) Regulates Aortic Valve Interstitial Cell CalcificationPreprint
Zhong, A., Adams, R. L. E., Mirzaei, Z., & Simmons, C. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4198999
Borkowski, T., Płoska, A., Smolenski, R. T., Khalpey, Z., Runyan, R. B., Bartoszewski, R., Jaguszewski, M., & Kalinowski, L. (2026) · Cardiology Journal · doi:10.5603/cj.105530
“Studies using murine models and human valve tissue suggest that modulation of purinergic ligands, receptors, or related enzymes can alter calcification [7, 8].”
Influential梁春阳, Zhu, L., Zhou, M., Shi, H., & Shao, G. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-13125-7
Metadata
- Authors
- Mahmut, A., Boulanger, M.-C., Bouchareb, R., Hadji, F., & Mathieu, P.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Mathieu, Patrick
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-02-02
- Volume
- 106
- Issue
- 1
- Pages
- 109-120
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W1995437010
- Cited by
- 48
- References
- 41
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 9 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 1
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval (MOP114893, MOP245048)
- Canadian Institutes of Health Research (MOP114893, MOP-245048)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Keywords
- calcific aortic valve disease, ectonucleotidases, adenosine, adenosine A2A receptor, NPP1, CD73, 5'-nucleotidase, valvular interstitial cells, calcification, cAMP/PKA/CREB pathway, extracellular nucleotides
- MeSH terms
- Bicuspid Aortic Valve Disease, Adenosine, Cyclic AMP, Adenosine Triphosphatases, Aged, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Disease Models, Animal, Female, Heart Defects, Congenital, Heart Valve Diseases, Humans, Male, Middle Aged, Phosphoric Diester Hydrolases, Pyrophosphatases, Signal Transduction, 5'-Nucleotidase, Cyclic AMP Response Element-Binding Protein, Cyclic AMP-Dependent Protein Kinases, Mice, Knockout, Receptor, Adenosine A2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.